Onyx Pharmaceuticals Inc Watch

from 8-K 7 pages Onyx Pharmaceuticals, Inc. as Issuer and Wells Fargo Bank, National Association as Trustee Second Supplemental Indenture Dated as of October 1, 2013 to Indenture Dated as of August 12, 2009 4.00% Convertible Senior Notes Due 2016

from S-3ASR 18 pages Onyx Pharmaceuticals, Inc. and , as Warrant Agent Debt Securities Warrant Agreement Dated as of Onyx Pharmaceuticals, Inc. Debt Securities Warrant Agreement

from S-3ASR 21 pages Onyx Pharmaceuticals, Inc. and , as Warrant Agent Preferred Stock Warrant Agreement Dated as of Onyx Pharmaceuticals, Inc. Preferred Stock Warrant Agreement

from S-3ASR 21 pages Onyx Pharmaceuticals, Inc. and , as Warrant Agent Common Stock Warrant Agreement Dated as of Onyx Pharmaceuticals, Inc. Common Stock Warrant Agreement

from S-3ASR 48 pages Onyx Pharmaceuticals, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [·], 20 Debt Securities

from 8-K 12 pages Unless This Certificate Is Presented by an Authorized Representative of the Depository Trust Company, a New York Corporation (“Dtc”), to the Company or Its Agent for Registration of Transfer, Exchange, or Payment, and Any Certificate Issued Is Registered in the Name of Cede & Co. or in Such Other Name as Is Requested by an Authorized Representative of Dtc (And Any Payment Is Made to Cede & Co. or to Such Other Entity as Is Requested by an Authorized Representative of Dtc), Any Transfer, Pledge or Other Use Hereof for Value or Otherwise by or to Any Person Is Wrongful Inasmuch as the Registered Owner Hereof, Cede & Co., Has an Interest Herein. This Note Is a Global Note Within the Meaning of the Indenture Hereinafter Referred to and Is Registered in the Name of a Depositary or a Nominee Thereof. This Note Is Exchangeable for Notes Registered in the Name of a Person Other Than the Depositary or Its Nominee Only in the Limited Circumstances Described in the Indenture And, Unless and Until It Is Exchanged in Whole or in Part for Notes in Definitive Form, This Note May Not Be Transferred Except as a Whole by the Depositary to a Nominee of the Depositary or by a Nominee of the Depositary to the Depositary or Another Nominee of the Depositary or by the Depositary or Any Such Nominee to a Successor Depositary or a Nominee of Such Successor Depositary.1 1 This Legend Is to Be Included Only if the Note Is a Global Note. 1 Onyx Pharmaceuticals, Inc. 4.00% Convertible Senior Notes Due 2016

from 8-K 78 pages Onyx Pharmaceuticals, Inc. as Issuer and Wells Fargo Bank, National Association as Trustee First Supplemental Indenture Dated as of August 12, 2009 to Indenture Dated as of August 12, 2009 4.00% Convertible Senior Notes Due 2016

from 8-K 51 pages Onyx Pharmaceuticals, Inc. Issuer and Wells Fargo Bank, National Association Trustee Indenture Dated as of August 12, 2009 Senior Debt Securities

from S-3ASR 32 pages Onyx Pharmaceuticals, Inc., Issuer and Wells Fargo Bank, N.A., Trustee Indenture Dated as of [• ], 200__ Subordinated Debt Securities

from S-3ASR 32 pages Onyx Pharmaceuticals, Inc. Issuer and Wells Fargo Bank, N.A. Trustee Indenture Dated as of [•], 200__ Senior Debt Securities

from S-3 22 pages Onyx Pharmaceuticals, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Onyx Pharmaceuticals, Inc. Form of Debt Securities Warrant Agreement

from S-3 25 pages Onyx Pharmaceuticals, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Onyx Pharmaceuticals, Inc. Form of Preferred Stock Warrant Agreement

from S-3 22 pages Onyx Pharmaceuticals, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Onyx Pharmaceuticals, Inc. Form of Common Stock Warrant Agreement

from S-3 53 pages Onyx Pharmaceuticals, Inc., Issuer and Wells Fargo Bank, N.A., Trustee Indenture Dated as of [• ], 200__ Subordinated Debt Securities

from S-3 52 pages Onyx Pharmaceuticals, Inc. Issuer and Wells Fargo Bank, N.A. Trustee Indenture Dated as of [•], 200__ Senior Debt Securities

from S-8 3 pages Certificate of Amendment of Amended and Restated Certificate of Incorporation of Onyx Pharmaceuticals, Inc

from S-3 3 pages Certificate of Amendment of Amended and Restated Certificate of Incorporation of Onyx Pharmaceuticals, Inc

from S-3 ~20 pages Indenture or similar

from S-3 ~20 pages Indenture or similar

from S-3 ~20 pages Indenture or similar